Corcept Therapeutics Incorporated
CORT
$69.57
$0.751.09%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -27.67% | -21.42% | 4.10% | 7.07% | 30.25% |
Total Receivables | 15.02% | -2.67% | -2.08% | 25.42% | 19.05% |
Inventory | 47.02% | 99.83% | 60.57% | 7.15% | 20.75% |
Prepaid Expenses | 88.36% | -60.94% | 119.77% | -15.31% | -66.27% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -20.53% | -- | -46.70% | -- | -- |
Total Current Assets | -20.99% | -12.89% | 2.83% | 8.22% | 29.65% |
|
|||||
Total Current Assets | -20.99% | -12.89% | 2.83% | 8.22% | 29.65% |
Net Property, Plant & Equipment | 2.18% | 3,990.43% | 2,443.81% | 1,656.88% | 1,004.32% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 40.31% | 35.79% | 33.89% | 38.23% | 39.23% |
Total Assets | 12.20% | 29.05% | 35.24% | 32.02% | 36.20% |
|
|||||
Total Accounts Payable | 20.74% | 122.56% | -11.61% | 11.21% | 144.28% |
Total Accrued Expenses | 49.14% | 57.19% | 73.22% | 66.56% | 49.87% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2,211.36% | 1,194.74% | 449.01% | 92.00% | -85.19% |
Total Finance Division Other Current Liabilities | 29.98% | -72.27% | -85.04% | -83.76% | -84.48% |
Total Other Current Liabilities | 29.98% | -72.27% | -85.04% | -83.76% | -84.48% |
Total Current Liabilities | 43.59% | 47.18% | 34.70% | 3.56% | 8.26% |
|
|||||
Total Current Liabilities | 43.59% | 47.18% | 34.70% | 3.56% | 8.26% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -0.66% | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 31.33% | 31.13% | 36.64% | 22.70% | 19.95% |
Total Liabilities | 40.25% | 50.98% | 40.20% | 9.88% | 14.85% |
|
|||||
Common Stock & APIC | 15.34% | 13.80% | 12.67% | 11.62% | 12.26% |
Retained Earnings | 28.70% | 31.14% | 35.08% | 38.21% | 37.08% |
Treasury Stock & Other | -32.88% | -16.10% | -9.76% | -7.69% | -5.97% |
Total Common Equity | 6.63% | 24.72% | 34.12% | 38.37% | 41.42% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 6.63% | 24.72% | 34.12% | 38.37% | 41.42% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 6.63% | 24.72% | 34.12% | 38.37% | 41.42% |
|